Breaking Out Of Our ‘Echo Chamber’ At Conferences

David G. Armstrong DPM MD PhD
1/16/12 | 2837 reads | 3 comments
As a new year begins, so does a new slate of podiatric scientific conferences. Podiatric physicians have no shortage of educational experiences from which to choose. Read More.

Where Is The Urgency For Treating Disastrous Non-Communicable Diseases (NCDs)?

David G. Armstrong DPM MD PhD
10/17/11 | 2775 reads | 0 comments
I was thinking recently about how we react to shared impending calamity (or challenge). The Allies worked together to battle a shared enemy in World War II. The Manhattan Project was an example of this (for better or worse). We worked together within the United States to reach the moon (as a challenge from Sputnik and our then adversaries in the U.S.S.R.). I am sure that if we faced a shared disaster such as a killer asteroid, we would all probably team up to nudge that rock into someone else's orbit. Read More.

Can 3D Templating And Simulation Enhance Surgical Planning?

David G. Armstrong DPM MD PhD
9/27/11 | 3481 reads | 0 comments
We at the Southern Arizona Limb Salvage Alliance (SALSA) have long embraced the benefits of interconnectivity and open source solutions. Surgical planning and collaboration are no exception. The concept of 3D surgical “printing” (templating and simulation) in lower extremity reconstruction is not entirely commonplace. This is likely for a number of reasons. With the continual maturation of free and open source software applications as well as the ever increasing capabilities of “RepRap” technology (see http://reprap.org/wiki/Main_Page ), we can overcome these limitations. Read More.

Taking Advantage Of ‘App’ Technology To Make Wound Care More Efficient

David G. Armstrong DPM MD PhD
8/2/11 | 2824 reads | 0 comments
For a number of years, we at the Southern Arizona Limb Salvage Alliance (SALSA) have been discussing the philosophical similarities between what we have called “wound chemotherapy” — or the instillation of therapeutics into a wound by way of a negative pressure wound therapy (NPWT) device — and the iPhone (or perhaps more apropos, the iPad). Imagine a day when you will be able to do the following. * Take a product like Vacuum Assisted Closure (VAC therapy, KCI), which might have instillation capabilities. Read More.

Rethinking Clinical Study Protocols To Include Patients With Neuroischemic Wounds

David G. Armstrong DPM MD PhD
7/5/11 | 4055 reads | 0 comments
We at the Southern Arizona Limb Salvage Alliance (SALSA) wanted to give a heads up to some of the work that has been occupying our time. We are now working on a piece on neuroischemic wounds with our friends Bill Marston, MD, from the University of North Carolina, and Kel Cohen, MD, an Emeritus Professor from Medical College of Virginia. We are all rather flummoxed that many clinical studies in which we participate — and from which our patients can benefit — systematically exclude patients for whom these treatments may provide the most benefit. Read More.

Are We Entering The Age Of Decay?

David G. Armstrong DPM MD PhD
6/10/11 | 2894 reads | 0 comments
I was listening to my favorite program the other night, BBC Radio 4's In Our Time. This program focused on “The Origins of Infectious Disease.” As usual, Melvyn Bragg puts forth a fascinating topic. One of the superb panelists, Steve Jones, BSc, PhD, a Professor of Genetics at University College London and a UK Stem Cell Foundation Trustee, pointed out that we could divide the roughly 200,000 years of Homo sapiens into the following three ages of death. The Age of Disaster: When we often met our demise as we were bitten, impaled or otherwise devoured. Read More.

A Spirit Of Collaboration At The International Symposium On The Diabetic Foot

David G. Armstrong DPM MD PhD
5/25/11 | 2778 reads | 2 comments
The sixth annual International Symposium on the Diabetic Foot (ISDF) recently met in the Netherlands to achieve a consensus for the next generation of worldwide guidelines for the diabetic foot. I was one of 1,000 participants from 77 nations to attend with one mission: improve the quality of care for patients with diabetes. Read More.

Can Fibrates Help Improve Sensation In Patients With Diabetic Neuropathy?

David G. Armstrong DPM MD PhD
4/6/11 | 3020 reads | 1 comments
At last year's Diabetic Foot Global Conference (DFCon10), Professor Tony Keech of Sydney, Australia, offered us some tantalizing evidence that fenofibrate had a net protective effect on preventing low-level amputations. While the rationale behind this was not entirely clear, further information at DFCon11 and further data seems to suggest the answer may lie in fenofibrate’s potential microvascular benefits. Read More.

Working Toward A Better Definition And Treatments For The Charcot Foot

David G. Armstrong DPM MD PhD
3/17/11 | 3245 reads | 0 comments
The American Diabetes Association and the American Podiatric Medical Association recently convened an international task force of experts to make recommendations on the diabetic Charcot foot. The meeting was located in Paris at the famous Pitié-Salpêtrière Hospital, the institution where Jean-Martin Charcot practiced in the 19th century. Read More.